• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    How Raised Earnings Guidance Will Impact Northrop Grumman Stock Investors

    Simply Wall St·11/01/2026 16:35:45
    Listen to the news
    • Northrop Grumman reported third quarter 2026 revenue of US$11.12b and net income of US$1.12b, and reaffirmed full year 2026 sales guidance of US$43.75b to US$44.25b, while raising earnings per share expectations.
    • Management linked the higher earnings outlook to stronger segment performance and a lower tax rate, which points to operational execution as the core driver rather than just financial engineering.
    • The focus will now be on how Northrop Grumman's raised earnings guidance may reshape the longer term investment narrative that analysts had outlined.
    Seize this earnings momentum in defense by scanning hand picked 29 resilient stocks with low risk scores that share Northrop Grumman's focus on resilient cash flows and balance sheet strength.

    Northrop Grumman Investment Narrative Recap

    To own Northrop Grumman, you need to be comfortable with a defense contractor that leans on big, long cycle U.S. programs and high capital spending to support future work in aircraft, missiles and space. The latest third quarter revenue of US$11.12b and net income of US$1.12b, plus higher 2026 EPS guidance, keep that execution story intact.

    The near term swing factor stays the same. Investors are watching how quickly large programs move deeper into production without fresh contract issues that compress margins. Budget or funding changes on platforms like B 21 or Sentinel remain the key risk, while elevated capex keeps free cash flow sensitivity front of mind.

    The most relevant update for that thesis is management reaffirming 2026 sales guidance of US$43.75b to US$44.25b while lifting earnings expectations by US$0.70 per share. Higher segment performance and a lower tax rate did the heavy lifting, even as corporate costs and interest expense also moved higher.

    That mix matters. Stronger operating units support the idea that Northrop Grumman can absorb cost pressure on complex fixed price work if execution stays tight. At the same time, the guidance reset does not remove core risks around high debt levels, ongoing capex plans and dependence on a concentrated set of large U.S. defense programs.

    What The Northrop Grumman Forecasts Are Really Asking You To Underwrite

    Northrop Grumman's analyst playbook is surprisingly clear once the headline numbers are stripped back. The story blends moderate top line expansion with only incremental earnings growth, and it assumes investors are comfortable paying a higher P/E multiple for that outcome by 2029.

    Consensus projections point to revenue climbing by 6.1% a year over the next three years. That is not a moonshot. It implies a business that steadily leans on its existing backlog and program ramps rather than banking on a step change in new awards. The twist is that margin expectations move the opposite way, with profit margins projected to shift from 10.4% today to 9.1% in three years. In other words, more sales are not automatically translating into richer profitability in these models.

    On the earnings line, analysts expect Northrop Grumman to move from US$4.5b in earnings today to US$4.8b by 2029, with a consensus earnings per share figure of US$34.03. That increase in profit of about US$0.3b is relatively modest compared with the scale of the current business, and the spread of views matters, because the more cautious end of the range is down at US$4.2b. For anyone tracking this stock into 2029, the gap between US$4.2b and US$4.8b is effectively the confidence interval around execution on large programs and cost control.

    Northrop Grumman's narrative projects US$52.1b revenue and US$4.8b earnings by 2029. This assumes 6.1% yearly revenue growth and an earnings increase of about US$0.3b from US$4.5b today.

    Valuation work in the consensus report then layers a multiple view on top of those operating forecasts. To line up with the US$636.0 price target, the stock would need to trade at a P/E of 23.8x on the 2029 earnings estimate. That compares with 17.4x today and sits below the cited 31.3x for the wider US Aerospace & Defense industry. In practical terms, analysts are not just assuming earnings reach US$4.8b by 2029; they are also assuming investors will accept paying a higher earnings multiple for that profile in four years' time.

    The same framework spells out the top and bottom of the valuation debate. The highest price target sits at US$815.0 and the lowest at US$430.0, which brackets a wide range of views on how comfortably Northrop Grumman can handle fixed price contract risk, capital spending and large program ramps. With the shares recently around US$552.77 and the consensus target 13.1% above that, the gap is not simply about timing. It reflects different judgements on whether future cash flows and earnings justify that higher implied P/E.

    One more moving part sits in the share count. Analysts expect the number of shares outstanding to fall by 0.46% per year over the next three years. Even modest buybacks can matter when combined with forecast earnings growth, because a smaller share base spreads the profit pie over fewer slices. That is how a relatively small move in absolute earnings, from US$4.5b to US$4.8b, can still keep the EPS line relevant to investors tracking capital returns alongside the operational story.

    Uncover why Northrop Grumman's fair value indicates a 14% potential upside to its current price that may not last much longer.

    NYSE:NOC 1-Year Stock Price Chart
    NYSE:NOC 1-Year Stock Price Chart

    Exploring Other Perspectives

    One alternate view zooms in on margin strain at Northrop Grumman. The most cautious analysts were modelling only US$49.7b of revenue and about US$4.2b of earnings by 2029 before this guidance, well below the consensus path. That camp effectively prices in recurring contract issues and invites you to compare both narratives as new quarterly data becomes available.

    Explore 2 other Northrop Grumman fair value estimates, including one that suggests it could be worth just $601.39.

    Reach Your Own Conclusion

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider conducting your own research.

    Looking For More Ideas Beyond Northrop Grumman?

    Once you are comfortable with the Northrop Grumman story, it can help to compare it with other companies that have very different risk and return profiles. The Simply Wall St Screener lets you quickly filter by quality, balance sheet strength and income profile so you can build a watchlist that aligns with your own goals.